Brachial-ankle pulse wave velocity is useful for evaluation of complications in type 2 diabetic patients

Hypertension Research

Volumn 26, Issue 10, 2003, Pages 807-813

  Aso, Katsumi ^a   Miyata, Masaaki ^a   Kubo, Tadahiro ^a   Hashiguchi, Hiroshi ^a   Fukudome, Michiyo ^a   Fukushige, Eriko ^a   Koriyama, Nobuyuki ^a   Nakazaki, Mitsuhiro ^a   Minagoe, Shinichi ^a   Tei, Chuwa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Albuminuria; Neuropathy; Pulse wave velocity; Retinopathy; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGE; AGED; ANKLE; AORTA; ARTERY COMPLIANCE; ARTICLE; BRACHIAL ARTERY; CAROTID ARTERY PULSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC RETINOPATHY; DIAGNOSTIC VALUE; DISEASE DURATION; DYSLIPIDEMIA; ELECTROCARDIOGRAM; FEMALE; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSCILLOMETRY; PERIPHERAL NEUROPATHY; PROTEINURIA; PULSE WAVE; RISK ASSESSMENT; RISK FACTOR; RR INTERVAL; SYSTOLIC BLOOD PRESSURE; TONOMETRY;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; ANKLE; AORTA; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; HYPERTENSION, RENAL; MALE; MIDDLE AGED; PULSATILE FLOW;

EID: 10744230561     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.26.807     Document Type: Article

References (21)

1. Woolam GL, Schnur PL, Vallbona C, Hoff HE: The pulse wave velocity as an early indicator of atherosclerosis in diabetic subjects. Circulation 1962; 25: 533-539.
2. Blacher J, Asmar R, Djane S, London GM, Safar ME: Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33: 1111-1117.
3. Moritani T, Crouse SF, Shea CH, Davidson N, Nakamura E: Arterial pulse wave velocity, Fourier pulsatility index, and blood lipid profiles. Med Sci Sports Exerc 1987; 19: 404-409.
4. Blacher J, Guerin AP, Pannier B, et al: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434-2439.
5. Hasegawa M, Nagao K, Kinoshita Y, Rodbard D, Asahira A: Increased pulse wave velocity and shortened pulse wave transmission time in hypertension and aging. Cardiology 1997; 88: 147-151.
6. Kubo T, Miyata M, Minagoe S, Setoyama S, Maruyama I, Tei C: A simple oscillometric technique for determining new indices of arterial distensibility. Hypertens Res 2002; 25: 351-358.
7. American Diabetes Association: Clinical practice recommendations. Diabetes Care 1999; 22 (Suppl 1): S11-S15.
8. 9 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension, Guidelines Subcommittee: 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 17: 151-183.
9. American Diabetes Association: Clinical practice recommendations. Diabetes Care 1999; 22(Suppl 1): S56-S59.
10. American Diabetes Association: Clinical practice recommendations. Diabetes Care 1999; 22 (Suppl 1): S66-S69.
11. Nagai Y, Sugiyama Y, Abe T, Nomura G: 4-g monofilament is clinically useful for the detection of diabetic peripheral neuropathy. Diabetes Care 2001; 24: 183-184.
12. Sasaki H, Nanjo K, Yamada M, et al: Diabetic neuropathy as a heterogeneous syndrome: multivariate analysis of clinical and neurological findings. Diabetes Res Clin Pract 1988; 4: 215-222.
13. Yamashina A, Tomiyama H, Takeda K, et al: Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-364.
14. Tanokuchi S, Okada S, Ota Z: Factors related to aortic pulse-wave velocity in patients with non-insulin-dependent diabetes mellitus. J Int Med Res 1995; 23: 423-430.
15. Okada S, Ishii K, Hamada H, et al: Relationship between cardiac autonomic neuropathy and diabetic microangiopathies and macroangiopathy in patients with non-insulin-dependent diabetes mellitus. J Int Med Res 1996; 24: 92-98.
16. Aso Y, Inukai T, Takemura Y: Evaluation of skin vasomotor reflexes in response to deep inspiration in diabetic patients by laser Doppler flowmetry: a new approach to the diagnosis of diabetic peripheral autonomic neuropathy. Diabetes Care 1997; 20: 1324-1328.
17. Scarpello JHB, Martin TRP, Ward JD: Ultrasound measurements of pulse-wave velocity in the peripheral arteries of diabetic subjects. Clin Sci 1980; 58: 53-57.
18. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes, UKPDS 38. Br Med J 1998; 317: 703-713.
19. Suzuki E, Kashiwagi A, Nishio Y, et al: Increased arterial wall stiffness limits flow volume in the lower extremities in type 2 diabetic patients. Diabetes Care 2001; 24: 2107-2114.
20. Safar ME, Levy BI, Laurent ST, et al: Hypertension and the arterial system: clinical and therapeutic aspects. J Hypertens 1990; 8 (Suppl 7): S113-S119.
21. Wang H, Hu D, Sun N, Gong L, Zhang W: Effect of long-acting isosorbide-5-mononitrate administration on large artery distensibility in patients with essential hypertension. Hypertens Res 2001; 24: 311-314.